Kapitalo Investimentos Ltda Intra Cellular Therapies, Inc. Transaction History

Kapitalo Investimentos Ltda

  • $410 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$64.37 - $75.65 $204,760 - $240,642
3,181 Added 864.4%
3,549 $246 Million
Q4 2023

Mar 29, 2024
BUY
$46.37 - $73.65 $17,064 - $27,103
368 New
368 $26.4 Million
Q3 2023

Mar 29, 2024
SELL
$52.09 - $64.1 $34,066 - $41,921
-654 Closed
0 $0
Q2 2023

Mar 29, 2024
BUY
$54.67 - $66.44 $35,754 - $43,451
654 New
654 $41.4 Million

Others Institutions Holding ITCI

# of Institutions
381
Shares Held
84M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $11.9B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Kapitalo Investimentos Ltda Portfolio

Follow Kapitalo Investimentos Ltda and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kapitalo Investimentos Ltda, based on Form 13F filings with the SEC.

News

Stay updated on Kapitalo Investimentos Ltda with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email